Peer Review reports
From: Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice
| Original Submission | ||
|---|---|---|
| 7 Mar 2024 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| 23 May 2024 | Reviewed | Reviewer Report |
| 17 Jun 2024 | Reviewed | Reviewer Report |
| 26 Jul 2024 | Author responded | Author comments - Xiaohe Li |
| Resubmission - Version 5 | ||
| 26 Jul 2024 | Submitted | Manuscript version 5 |
| 5 Aug 2024 | Reviewed | Reviewer Report |
| 6 Aug 2024 | Reviewed | Reviewer Report |
| 15 Aug 2024 | Author responded | Author comments - Xiaohe Li |
| Resubmission - Version 6 | ||
| 15 Aug 2024 | Submitted | Manuscript version 6 |
| 29 Aug 2024 | Reviewed | Reviewer Report |
| Resubmission - Version 7 | ||
| Submitted | Manuscript version 7 | |
| Publishing | ||
| 4 Sep 2024 | Editorially accepted | |
| 16 Sep 2024 | Article published | 10.1186/s12890-024-03273-6 |
You can find further information about peer review here.